Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: Graft-versus-host disease and transplant-related mortality

Journal of Clinical Oncology

Volumn 17, Issue 3, 1999, Pages 806-812

  Brown, Randy A ^a   Adkins, D ^a   Khoury, H ^a   Vij, R ^a   Goodnough, L T ^a   Shenoy, S ^a   DiPersio, J F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LEUKEMIA; ADULT; ALLOTRANSPLANTATION; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; GRAFT VERSUS HOST REACTION; HUMAN; MORTALITY; MYELODYSPLASTIC SYNDROME; MYELOMA; NONHODGKIN LYMPHOMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

EID: 0032976781     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.3.806     Document Type: Article

References (38)

1. Wingard J: Prevention and treatment of bacterial and fungal infections. Bone Marrow Transplant 27:363-375, 1994
2. Brown R, Adkins D, Goodnough L, et al: Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies. J Clin Oncol 15:3067-3074, 1997
3. Bensinger W, Weaver C, Appelbaum F, et al: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655-1658, 1995
4. Korbling M, Przepiorka D, Huh Y, et al: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma. Potential advantage of blood over marrow allografts. Blood 85:1659-1665, 1995
5. Przepiorka D, Anderlini P, Ippoliti C, et al: Allogeneic blood stem cell transplantation in advanced hematologic cancers. Bone Marrow Transplant 19:455-460, 1997
6. Bensinger WI, Clift R, Martin P, et al: Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation. Blood 88:2794-2800, 1996
7. Pavletic ZS, Bishop M, Stefano R, et al: Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies. J Clin Oncol 15:1608-1616, 1997
8. Schmitz N, Bacigalupo A, Hasenclever D, et al: Allogeneic bone marrow transplantation vs filgrastrim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: First results of a randomized multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 21:995-1003, 1998
9. Yam PY, Petz LG, Knowlton, RG, et al: Use of DNA restriction fragment length polymorphism to document marrow engraftment and mixed hematopoietic chimerism following bone marrow transplantation. Transplantation 43:399-407, 1987
10. Ugozzoli L, Yam P, Petz LD, et al: Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantation. Blood 77:1607-1615, 1991
11. Glucksberg H, Storb R, Fefer A, et al: Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 18:295-304, 1974
12. Shulman H, Sullivan K, Weiden P, et al: Chronic graft-versus-host syndrome in man. Am J Med 69:204-217, 1980
13. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
14. Russell A, Brown C, Bowen T, et al: Allogeneic blood cell transplants for haematological malignancy: Preliminary comparison of outcomes with bone marrow transplantation. Bone Marrow Transplant 17:703-708, 1996
15. Clark A, Cook G, Chopra R, et al: Allogeneic sibling PBSC transplantation results in improved engraftment kinetics but is associated with a high incidence of chronic GVHD. Blood 90:376a, 1997 (abstr 1672)
16. Gale RP, Bortin MM, Van Bekkum DW, et al: Risk factors for acute graft-versus-host disease. Br J Haematol 67:397-406, 1987
17. Storb R, Doney K, Thomas E, et al: Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. Blood 59:236-246, 1982
18. Schmitz N, Bacigalupo A, Labopin M, et al: Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. Br J Haematol 95:715-723, 1996
19. Bacigalupo A, VanLint M, Valbonesi M et al : Thiotepa, cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia. Blood 88:353-357, 1996
20. Miflin G, Russell NH, Hutchinson RM, et al: Allogeneic peripheral blood stem cell transplantation for haematological malignancy. Bone Marrow Transplant 19:9-13, 1997
21. Storek J, Gooley T, Siadak M, et al: Allogeneic peripheral blood stem cell transplantation may be associated with high risk of chronic graft-versus-host disease. Blood 12:4705-4709, 1997
22. Deeg HJ, Lin D, Leisenring W, et al: Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: A prospective, randomized trial. Blood 89:2887-3880, 1997
23. Atkinson K, Horowitz Mary, Gale R, et al: Risk factors for chronic graft-vs-host disease after HLA-identical sibling bone marrow transplantation. Blood 75:2459-2464, 1990
24. Korbling M, Mirza N, Przepiorka D, et al: Clinical outcome in 112 patients following HLA-identical allogeneic peripheral blood stem cell transplantation. Blood 90:224a, 1997 (abstr 989)
25. Falda M, Majolino I, Di Bartolomeo P, et al: Allogeneic peripheral blood stem cell transplantation: GITMO experience. Bone Marrow Transplant 19:573, 1997 (suppl 1) (abstr)
26. Rosenfeld C, Weinthal C, Collins R, et al: Does CD34 content of allogeneic blood cell transplants predict acute GVHD? Blood 88:616a, 1996 (abstr 2453)
27. Sullivan KM, Agura E, Anasetti C, et al: Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 28:250-259, 1991
28. Van Rhee F, Szydlo RM, Hermans J, et al: Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: A report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 20:553-560, 1997
29. Chao NJ, Schmidt GM, Niland JC, et al: Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-vs-host disease. N Engl J Med 329:1225-1230, 1993
30. Ringden O, Horowitz MM, Sonderl P, et al: Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia. Blood 81:1094-1101, 1993
31. Ottinger HD, Beelen DW, Scheulen B, et al: Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 88:2775-2779, 1996
32. Pan L, Delmonte J Jr, Jalonen CK, et al: Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward Type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 86:4422-4429, 1995
33. Shenoy S, Brown R, Adkins D, et al: Constitutive peripheral blood cytokine mRNA expression in growth factor-mobilized normal donors and allogeneic peripheral blood stem cell transplant recipients. Blood 90:561a, 1997 (abstr 2501)
34. Talmadge JE, Reed EC, Kessinger A, et al: Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation. Bone Marrow Transplant 17:101-109, 1996
35. Buyukberber S, Singh RK, Varney ML, et al: Peripheral stem cell products contain monocytes which induce apoptosis of activated T lymphocytes by Fas ligand expression. Blood 90:40b, 1997 (abstr 2871)
36. Brown RA, Wolff SN, Fay JW, et al: High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: A study by the North American Marrow Transplant Group. Leuk Lymphoma 18:179-184, 1995
37. Gale RP, Horowitz MM, Rees JKH, et al: Chemotherapy versus transplants for acute myelogenous leukemia in second remission. Leukemia 10:13-19, 1996
38. Passweg JR, Rowlings PA, Atkinson KA, et al: Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia. Bone Marrow Transplant 21:1231-1238, 1998